52 results
-
Public consultation on items to be considered by the PBAC (March 2025)
Consultation has opened for the March 2025 Pharmaceutical Benefits Advisory Committee (PBAC) agenda. The PBAC welcomes input from patients, carers, health professionals, consumer groups or organisations and members of the public on medicines submitted for PBAC consideration. The PBAC considers these public consultation inputs when considering the clinical and economic evidence presented by the applicant. How to provide input Input can be submitted via the online... MoreOpened 27 November 2024 -
MSAC Consultation Survey - Application 1762
Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care environment. It does this by providing MSAC with an insight into the potential effect of the proposed health service or... MoreOpened 27 November 2024 -
REGISTER for "Enhancing Conversations" Consumer Webinar, 10 December 2024
The Chair of the Health Technology Assessment (HTA) Consumer Consultative Committee (CCC), Ms Jo Watson, is hosting a webinar for health consumers and health consumer organisations with an interest in HTA. The two-hour webinar is titled “Enhancing Conversations – Reflections on an Extraordinary Year”. It will provide an opportunity to acknowledge some of the many highlights of the consumer sector during 2024 and look towards enhancing consumer engagement in HTA in 2025.... MoreOpened 6 November 2024 -
MSAC Consultation Survey - Application 1555.1
Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care environment. It does this by providing MSAC with an insight into the potential effect of the proposed health service or... MoreOpened 23 October 2024 -
MSAC Consultation Survey - Application 1657.1
Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care environment. It does this by providing MSAC with an insight into the potential effect of the proposed health service or... MoreOpened 23 October 2024 -
MSAC Consultation Survey - Application 1708.1
Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care environment. It does this by providing MSAC with an insight into the potential effect of the proposed health service or... MoreOpened 23 October 2024 -
MSAC Consultation Survey - Application 1754
Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care environment. It does this by providing MSAC with an insight into the potential effect of the proposed health service or... MoreOpened 23 October 2024 -
MSAC Consultation Survey - Application 1767
Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care environment. It does this by providing MSAC with an insight into the potential effect of the proposed health service or... MoreOpened 23 October 2024 -
MSAC Consultation Survey - Application 1769
Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care environment. It does this by providing MSAC with an insight into the potential effect of the proposed health service or... MoreOpened 23 October 2024 -
MSAC Consultation Survey - Application 1774
Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care environment. It does this by providing MSAC with an insight into the potential effect of the proposed health service or... MoreOpened 23 October 2024 -
MSAC Consultation Survey - Application 1772
Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care environment. It does this by providing MSAC with an insight into the potential effect of the proposed health service or... MoreOpened 23 October 2024 -
MSAC Consultation Survey - Application 1776
Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care environment. It does this by providing MSAC with an insight into the potential effect of the proposed health service or... MoreOpened 23 October 2024 -
MSAC Consultation Survey - Application 1779
Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care environment. It does this by providing MSAC with an insight into the potential effect of the proposed health service or... MoreOpened 23 October 2024 -
MSAC Consultation Survey - Application 1782
Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care environment. It does this by providing MSAC with an insight into the potential effect of the proposed health service or... MoreOpened 23 October 2024 -
MSAC Consultation Survey - Application 1791
Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care environment. It does this by providing MSAC with an insight into the potential effect of the proposed health service or... MoreOpened 23 October 2024 -
MSAC Consultation Survey - Application 1785
Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care environment. It does this by providing MSAC with an insight into the potential effect of the proposed health service or... MoreOpened 27 September 2024 -
MSAC Consultation Survey - Application 1786
Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care environment. It does this by providing MSAC with an insight into the potential effect of the proposed health service or... MoreOpened 27 September 2024 -
MSAC Consultation Survey - Application 1787
Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care environment. It does this by providing MSAC with an insight into the potential effect of the proposed health service or... MoreOpened 27 September 2024 -
MSAC Consultation Survey - Application 1788
Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care environment. It does this by providing MSAC with an insight into the potential effect of the proposed health service or... MoreOpened 27 September 2024 -
MSAC Consultation Survey - Application 1789
Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care environment. It does this by providing MSAC with an insight into the potential effect of the proposed health service or... MoreOpened 27 September 2024 -
Public consultation on items to be considered by the PBAC (July 2024)
Consultation has opened for the July 2024 Pharmaceutical Benefits Advisory Committee (PBAC) agenda. The PBAC welcomes input from patients, carers, health professionals, consumer groups or organisations and members of the public on medicines submitted for PBAC consideration. The PBAC considers these public consultation inputs when considering the clinical and economic evidence presented by the applicant. How to provide input Input can be submitted via the online... MoreOpened 3 April 2024 -
Nurse practitioner and midwife PBS prescribing consultation survey
Consultation is now open for the Review of Pharmaceutical Benefits Scheme (PBS) prescribing by authorised nurse practitioners (notated as ‘NP’ on the PBS schedule) and endorsed midwives (notated as ‘MW’ on the PBS schedule) (the PBS Review). The Department of Health and Aged Care (The Department) is currently undertaking a review for consideration by the Pharmaceutical Benefits Advisory Committee (PBAC) of PBS medicines that may be suitable for prescribing by nurse practitioners... MoreOpened 1 March 2024 -
Public consultation on applications to be considered by the MSAC (August 2024)
Consultation is now open for applications that are anticipated to be considered by the Medical Services Advisory Committee (MSAC) on 1-2 August 2024. MSAC values consultation input from individuals and organisations with an interest in an application that it is considering, including experience of the medical conditions, services or technologies being addressed by the application. It is anticipated that the below-mentioned applications will proceed to MSAC in June 2024.... MoreOpened 28 February 2024 -
Public consultation on applications to be considered by the MSAC PASC (April 2024)
Consultation is now open for applications that are anticipated to be considered by the PICO Advisory Sub-Committee (PASC) of the Medical Services Advisory Committee (MSAC) on 18-19 April 2024. PASC values consultation input from individuals and organisations with an interest in an application that it is considering, including experience of the medical conditions, services or technologies being addressed by the application. It is anticipated that the below-mentioned applications... MoreOpened 2 February 2024 -
Health Technology Assessment Policy and Methods Review - Consultation 2
The Options Paper developed through the Health Technology Assessment Policy and Methods Review (HTA Review) has been published. You can access it through the 'Related' documents link, located at the end of this page. This paper presents options for reform being considered by the Reference Committee to improve Australia’s HTA policies and methods and the funding and approval pathways. The aim of this paper is to facilitate stakeholder feedback on the potential options for reform... MoreOpened 25 January 2024 -
Public consultation on items to be considered by the PBAC (March 2024)
Consultation has opened for the March 2024 Pharmaceutical Benefits Advisory Committee (PBAC) agenda. The PBAC welcomes input from patients, carers, health professionals, consumer groups or organisations and members of the public on medicines submitted for PBAC consideration. The PBAC considers these public consultation inputs when considering the clinical and economic evidence presented by the applicant. How to provide input Input can be submitted via the online... MoreOpened 22 November 2023 -
Public consultation on applications to be considered by the MSAC (April 2024)
Consultation is now open for applications that are anticipated to be considered by the Medical Services Advisory Committee (MSAC) on 4-5 April 2024. MSAC values consultation input from individuals and organisations with an interest in an application that it is considering, including experience of the medical conditions, services or technologies being addressed by the application. It is anticipated that the below-mentioned applications will proceed to MSAC in April 2024.... MoreOpened 18 October 2023 -
Public consultation for MSAC Draft Framework for the Assessment of Radiopharmaceuticals
The Medical Services Advisory Committee (MSAC) has developed a Draft Framework for the MSAC assessment of radiopharmaceuticals. The purpose of this Framework is to identify the supplementary information requirements to those set out in the Guidelines for preparing assessments for the Medical Services Advisory Committee (“MSAC Guidelines”) to ensure that radiopharmaceuticals to be used within the scope of a proposed MBS item descriptor in an application for a new or... MoreOpened 10 October 2023 -
Public consultation on applications to be considered by the MSAC PASC (December 2023)
Consultation is now open for applications that are anticipated to be considered by the PICO Advisory Sub-Committee (PASC) of the Medical Services Advisory Committee (MSAC) on 7-8 December 2023. PASC values consultation input from individuals and organisations with an interest in an application that it is considering, including experience of the medical conditions, services or technologies being addressed by the application. It is anticipated that the below-mentioned applications... MoreOpened 22 September 2023 -
Expression of Interest: Consumer Member of the Enhanced Consumer Engagement Process Co-design Group
The 2022-2027 Strategic Agreement between the Commonwealth and Medicines Australia includes a commitment to the co-design of an Enhanced Consumer Engagement Process (clause 6.3.2). The co-design aims to facilitate the capture of consumer and patient perspectives earlier in the health technology assessment (HTA) process to assist the Pharmaceutical Benefits Advisory Committee and other HTA advisory bodies to obtain an understanding of issues arising from new technologies, innovations... MoreOpened 7 August 2023
52 results.
Page 1 of 2